Dosey et al. (2026) “Stabilization of the H5 clade 2.3.4.4b hemagglutinin improves vaccine-elicited neutralizing antibody responses in mice” Science Translational Medicine.
DOI: 10.1126/scitranslmed.aea8770
Read about Dosey et al. (2026) “Stabilization of the H5 clade 2.3.4.4b hemagglutinin improves vaccine-elicited neutralizing antibody responses in mice” Science Translational Medicine.
Oyedele et al. (2026) “A novel SARS-CoV-2 mRNA virus-like particle vaccine is highly potent and well tolerated in adults in a phase 1 randomized clinical trial” Vaccine.
DOI: 10.1016/j.vaccine.2026.128304
Read about Oyedele et al. (2026) “A novel SARS-CoV-2 mRNA virus-like particle vaccine is highly potent and well tolerated in adults in a phase 1 randomized clinical trial” Vaccine.
Castaño et al. (2025) “Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses” Cell.
DOI: 10.1016/j.cell.2025.11.023
Read about Castaño et al. (2025) “Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses” Cell.
Laliberte et al. (2025) “Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2” NPJ Vaccines.
DOI: 10.1038/s41541-025-01303-w
Read about Laliberte et al. (2025) “Immunogenicity and efficacy of an mRNA vaccine expressing a virus-like particle spike antigen against SARS-CoV-2” NPJ Vaccines.
Yengo et al. (2025) “Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations” Frontiers in Immunology.
DOI: 10.3389/fimmu.2025.1722596
Read about Yengo et al. (2025) “Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations” Frontiers in Immunology.
Styles et al. (2025) “Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques” Cell Reports Medicine.
DOI: 10.1016/j.xcrm.2025.102369
Read about Styles et al. (2025) “Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques” Cell Reports Medicine.
Lawtrakulngam et al. (2025) “Enhancing osseointegration with LNP-delivered mRNA–encoded BMP-2: An experimental in vivo study” Clinical Oral Implants Research.
DOI: 10.1111/clr.70057
Read about Lawtrakulngam et al. (2025) “Enhancing osseointegration with LNP-delivered mRNA–encoded BMP-2: An experimental in vivo study” Clinical Oral Implants Research.
Hendricks et al. (2025) “Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice” Science Translational Medicine.
DOI: 10.1126/scitranslmed.adu2085
Read about Hendricks et al. (2025) “Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice” Science Translational Medicine.
Janjuha et al. (2025) “Spatial profiling of gene editing by in situ sequencing in mice and macaques” Nature Biomedical Engineering.
DOI: 10.1038/s41551-025-01512-7
Read about Janjuha et al. (2025) “Spatial profiling of gene editing by in situ sequencing in mice and macaques” Nature Biomedical Engineering.
Limsalakpetch et al. (2025) “mRNA-LNP vaccine encoding the Plasmodium vivax circumsporozoite protein is highly immunogenic and confers protection in mice” Molecular Therapy Nucleic Acids.
DOI: 10.1016/j.omtn.2025.102645
Read about Limsalakpetch et al. (2025) “mRNA-LNP vaccine encoding the Plasmodium vivax circumsporozoite protein is highly immunogenic and confers protection in mice” Molecular Therapy Nucleic Acids.
Limeres et al. (2025) “mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models” Molecular Therapy.
DOI: 10.1016/j.ymthe.2025.06.027
Read about Limeres et al. (2025) “mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models” Molecular Therapy.
Shuvaev et al. (2025) “Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo” PNAS.
DOI: 10.1073/pnas.2409266122
Read about Shuvaev et al. (2025) “Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo” PNAS.